Skip to main content

Table 1 Baseline characteristics of the study population

From: Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium

Characteristics (n = 425)

N (%)

Age (years) mean ± SD (range)

41.6 ± 10.8

Gender (male)

335 (78.8)

Country of birth

 Belgium

333 (78.4)

 Other

91 (21.4)

 Missing

1 (0.2)

Source of income last 6 months

 Employment

87 (20.5)

 Welfare check

254 (59.8)

 Pension

13 (3.1)

 None

68 (16.0)

 Missing

3 (0.7)

Housing last 6 months

 At home (owned/rented)

225 (52.9)

 Residential/family/friends

122 (28.7)

 Prison/homeless

78 (18.4)

 Missing

2 (0.5)

Level of education

 Primary school (7–12 years)

22 (5.2)

 Partly completed high school (< 16 years)

130 (30.6)

 Completed high school (18 years)

206 (48.4)

 Higher education (> 18 years)

66 (15.5)

 Missing

1 (0.2)

Ever have been incarcerated (yes)

227 (53.4)

Alcohol abuse

 Active (< 6 m)

122 (28.7)

 Former

126 (29.6)

 Never

175 (41.2)

 Missing

2 (0.5)

Age of first drug use (years) mean ± SD (range)

18 ± 8.1

Ever IV drug use (yes)

148 (34.8)

Recent (< 6 m) IDU (n = 148)

73 (49.3)

Recently (< 6 m) injected not connected to NSP (n = 73)

13 (17.8)

Recently (< 6 m) used opioid not connected to OAT (n = 97)

47 (48.5)

  1. IV intravenous, OAT opiate agonist therapy, NSP needle syringe program